Research Article
Effects of 8-Prenylnaringenin and Whole-Body Vibration Therapy on a Rat Model of Osteopenia
Table 1
Body weight, μCT, protein expression, and serum analysis data after treatment with WBVV, 8-PN, or combined therapy.
| | non-OVX | OVX | OVX + VIB | OVX-8-PN | OVX-8-PN + VIB | Sample size | 11 | 11 | 11 | 11 | 12 | | Mean | STD | Mean | STD | Mean | STD | Mean | STD | Mean | STD |
| Bodyweight | | | | | | | | | | | Pre-OVX [g] | 258.0 | 8.9 | 264.3 | 13.8 | 258.3 | 11.8 | 264.1 | 10.8 | 257.5 | 14.8 | After 15 weeks [g] | 346.6 | 19.1 | 400.7 | 47.4 | 392.5 | 24.0 | 388.3 | 21.3 | 367.0 | 22.1 | µCT vertebrae | | | | | | | | | | | Trabecular number (Tb.N) [] | 111.5 | 26.98 | 117.5 | 25.56 | 105.4 | 27.27 | 117.6 | 25.45 | 113.8 | 27.91 | Number of trabecular nodes N.Nd [] | 133.8 | 36.76 | 140.8 | 34.79 | 122.8 | 36.33 | 143.6 | 36.05 | 137.1 | 37.56 | Mean trabecular junctions at one node (Tb.N/Nd) [] | 2.33 | 0.14 | 2.33 | 0.16 | 2.25 | 0.14 | 2.37 | 0.14 | 2.36 | 0.17 | Trabecular thickness (Tb.Th) [mm] | 0.05669 | 0.02143 | 0.04956 | 0.02006 | 0.04975 | 0.0138 | 0.04884 | 0.01932 | 0.04827 | 0.02725 | BV/TV whole body of vertebrae [%] | 43.82 | 3.22 | 39.84 | 1.94 | 42.66 | 4.46 | 41.68 | 5.82 | 43.32 | 2.92 | BV/TV trabecular bone [%] | 52.55 | 6.75 | 48.53 | 7.04 | 47.30 | 8.53 | 50.13 | 9.24 | 58.03 | 15.85 | Cortical thickness (CTTh) [mm] | 0.2367 | 0.0212 | 0.1977 | 0.0393 | 0.2116 | 0.0412 | 0.2042 | 0.0356 | 0.2021 | 0.0408 | Microradiographic analysis femora | | | | | | | | | | | Trabecular nodes (N.Nd) [] | 109.1 | 21.7 | 87.5 | 19.2 | 78.4 | 23.1 | 87.0 | 8.7 | 91.6 | 9.9 | Trabecular connectivity [N.Nd/mm2] | 21.85 | 3.93 | 16.97 | 3.29 | 14.09 | 4.13 | 16.32 | 1.46 | 17.21 | 2.87 | Trabecular bone area [mm2] | 4.99 | 0.45 | 5.16 | 0.70 | 5.62 | 0.69 | 5.33 | 0.28 | 5.39 | 0.64 | Trabecular thickness (Tb.Wi) [mm] | 0.00698 | 0.00171 | 0.00597 | 0.00079 | 0.00564 | 0.00056 | 0.00553 | 0.00071 | 0.00572 | 0.00071 | Trabecular density [%] | 75.50 | 11.77 | 58.50 | 10.29 | 50.80 | 10.75 | 53.80 | 7.15 | 56.48 | 9.99 | Cortical density [%] | 97.44 | 1.41 | 96.62 | 1.49 | 97.03 | 0.96 | 96.52 | 0.88 | 96.14 | 1.22 | Ashing | | | | | | | | | | | Mineral content (%) | 43.00 | 7.59 | 37.82 | 1.66 | 35.97 | 1.54 | 37.46 | 1.68 | 36.00 | 2.10 | Ca2+/ | 1.541 | 0.065 | 1.500 | 0.220 | 1.562 | 0.156 | 1.609 | 0.065 | 1.569 | 0.031 | Gene expression | | | | | | | | | | | ALP | 1.056 | 0.325 | 0.825 | 0.190 | 1.376 | 0.435 | 1.300 | 0.584 | 1.665 | 0.238 | Osteocalcin | 1.114 | 0.574 | 1.631 | 0.549 | 2.066 | 1.085 | 1.142 | 0.471 | 1.306 | 0.537 | RANKL | 1.199 | 0.556 | 1.956 | 0.310 | 2.938 | 0.874 | 2.054 | 0.633 | 1.661 | 0.816 | OPG | 1.218 | 0.968 | 1.296 | 0.732 | 1.595 | 1.066 | 1.472 | 1.756 | 2.187 | 1.801 | TRAP | 1.069 | 0.494 | 1.152 | 0.248 | 1.136 | 0.569 | 0.867 | 0.471 | 0.841 | 0.384 | Serum analysis | | | | | | | | | | | ALP [U/I] serum | 91.4 | 15.37 | 113.4 | 18.34 | 149.6 | 33.8 | 137.4 | 28.07 | 135.9 | 8.39 |
|
|
versus OVX. versus adjunctive VIB. versus non-OVX.
|